New Drug Option for Patients with Melanoma
Monday September 12, 2011
Last month, the FDA approved the drug Zelboraf (vemurafenib) for patients with melanoma, the deadliest form of skin cancer. The drug is designed to work only for late-stage melanoma patients ... Read More